The Full Wiki

More info on GYKI-52,895

GYKI-52,895: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

(Redirected to GYKI-52895 article)

From Wikipedia, the free encyclopedia

GYKI-52895
Systematic (IUPAC) name
4-{13-methyl-4,6-dioxa-11,12-diazatricyclo[7.5.0.0 3,7]tetradeca-1,3(7),8,10-tetraen-10-yl}aniline
Identifiers
CAS number 869360-93-0
ATC code  ?
PubChem 3539
Chemical data
Formula C 17H17N3O2  
Mol. mass 295.34
Synonyms 4-(8,9-Dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)benzenamine
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status
Routes  ?

GYKI-52895 is a drug which is a 2,3-benzodiazepine derivative. Unlike other similar drugs, GYKI-52895 is a selective dopamine reuptake inhibitor,[1][2] which presumably would produce stimulant effects in vivo.

See also

References

  1. ^ Horváth K, Szabó H, Pátfalusi M, Berzsenyi P, Andrási F. Pharmacological Effects of GYKI 52895, a New Selective Dopamine Uptake Inhibitor. European Journal of Pharmacology. 1990; 183(4):1416-1417.
  2. ^ Huang CL, Chen HC, Huang NK, Yang DM, Kao LS, Chen JC, Lai HL, Chern Y. Modulation of Dopamine Transporter Activity by Nicotinic Acetylcholine Receptors and Membrane Depolarization in Rat Pheochromocytoma PC12 Cells. Journal of Neurochemistry. 1999; 72(6): 2437–2444.
Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message